Study guide
3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels
NAWCCB WCC Wound Care Certified Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the NAWCCB WCC Exam How to Use This Study Guide
2 Assessment: Skin & Tissue Foundations
1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric
3 Assessment: Diagnostic Tools & Risk Assessment
2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
4 Treatment: Dressing Selection & Debridement Modalities
3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical
5 Treatment: Advanced Therapies & Specialized Management
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT
6 Reevaluation & Wound Healing Trajectory
5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence
7 Risk Reduction & Prevention Strategies
6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment
8 Patient & Caregiver Education
7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media
9 Administration & Program Management
8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization
10 Legal, Ethical, & Scope of Practice
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection
3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels
Key Takeaways Explain This Topic AI
Hydrocolloids consist of gel-forming polymer particles (CMC, pectin, gelatin) suspended in an adhesive matrix; they promote autolytic debridement but are strictly contraindicated in infected wounds.
Transparent polyurethane films are semi-permeable, non-absorptive dressings that allow oxygen and water vapor exchange while blocking liquid water, bacteria, and shear forces.
Hydrogels contain 80% to 90% water and act primarily as moisture donors to rehydrate dry eschar, soften avascular slough, and facilitate endogenous autolytic debridement.
Hydrocolloid dressing changes produce a characteristic yellow, foul-smelling gelatinous liquefaction that must be distinguished from purulent wound infection.
Transparent films applied over moderate-to-heavy exudative wounds cause rapid fluid accumulation and severe periwound skin maceration.
Last updated: August 2026
Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels
While high-absorbency dressings manage fluid excess, dry or minimally exudative wounds require topical modalities that prevent evaporation, protect fragile new tissue from external friction, or actively donate moisture. The three primary dressing classes designed for hydration, occlusion, and barrier protection are hydrocolloids , transparent polyurethane films , and hydrogels .
- 1. Hydrocolloid Dressings
- Composition and Structure
Hydrocolloid dressings are wafer-like dressings consisting of an inner adhesive layer containing hydrophilic, gel-forming colloidal particles—specifically sodium carboxymethylcellulose (CMC) , pectin , and gelatin —suspended within an elastomeric matrix, backed by a outer layer of polyurethane film or foam.
Mechanism of Action: Gel Liquefaction & Occlusion
As the hydrocolloid absorbs small amounts of wound exudate, the hydrophilic particles swell and melt into a soft, gelatinous mass over the wound bed. This process creates an occlusive or semi-occlusive hypoxic environment with high localized humidity. HYDROCOLLOID STRUCTURE & LIQUEACTION PROCESS
- +-------------------------------------------------------------+
- | Outer Polyurethane Film Backing (Waterproof/Bacteria-proof) |
- +-------------------------------------------------------------+
- | Elastomeric Adhesive Matrix containing: |
- | [ Sodium CMC ] [ Pectin ] [ Gelatin ] |
- +-------------------------------------------------------------+
- | (Contact with wound fluid)
- v
- +-------------------------------------------------------------+
- | Yellowish Gelatinous Melt (Foul-smelling, hypoxic gel) |
- | - Softens slough via trapped endogenous proteolytic enzymes |
- | - Promotes angiogenesis via mild localized hypoxia |
- +-------------------------------------------------------------+
Clinical Features & Advantages:
Autolytic Debridement: Traps endogenous proteolytic enzymes (MMPs, elastase) and moisture against necrotic tissue, accelerating natural autolysis.
Bacterial & Viral Barrier: Impermeable to liquid water, environmental contaminants, and pathogens including Methicillin-Resistant Staphylococcus aureus (MRSA), Hepatitis B virus, and HIV.
Thermal & Mechanical Protection: Cushions fragile tissue and maintains normothermia.
Wear Time: Can remain in place for 3 to 7 days . Change when the gel residue bubble expands to within 1 cm of the dressing margin .
Critical Clinical Warnings:
Foul-Smelling Gel Residue: When removed, hydrocolloids leave a yellowish, thick, foul-smelling residue in the wound bed. Inexperienced clinicians frequently misdiagnose this normal chemical melt as purulent drainage from a wound infection. Action: Thoroughly cleanse the wound bed with normal saline prior to assessing for true infection.
Absolute Contraindication in Infection: Hydrocolloids must NEVER be applied to infected wounds . Occlusion creates an ideal anaerobic environment for pathogenic bacterial proliferation ( Clostridium , Pseudomonas ).
Contraindicated in Heavily Exudative Wounds & Deep Sinus Tracts: Exudate accumulation causes rapid edge detachment and maceration.
Loading diagram... Barrier & Hydrating Dressing Selection Matrix
- 2. Transparent Film Dressings
- Composition & Permeability Characteristics
Transparent film dressings are thin, flexible sheets of polyurethane coated with a hypoallergenic acrylic adhesive. They are semi-permeable :
Permeable to: Oxygen ( O 2 O_2 O 2 ) and water vapor (Moisture Vapor Transmission Rate - MVTR).
Impermeable to: Liquid water, external fluids, bacteria, and viral pathogens.
Key Clinical Indications:
Friction and Shear Reduction: Reduces friction coefficients on high-risk bony prominences (e.g., heels, sacrum in non-exudative Stage 1 pressure injuries).
Superficial Epithelial Protection: Primary dressing for partial-thickness donor sites, superficial skin tears, and clean IV catheter insertion sites.
Secondary Securement: Ideal secondary cover to anchor primary alginates, hydrofibers, or gauze.
Autolytic Environment: Retains native wound moisture over shallow, minimally exudative clean wounds.
Contraindications & Removal Technique:
Zero Absorbency: Transparent films cannot absorb liquid. Applying a film over a moderate-to-heavily draining wound results in rapid fluid pooling, wound destabilization, and severe periwound maceration.
Contraindicated in infected wounds or third-degree burns.
Removal Technique: Do not pull film upward off skin. Stretch the film horizontally parallel to the skin surface ("stretch-and-release") to break the acrylic adhesive bond without causing epidermal stripping.
- 3. Hydrogel Dressings
- Formulations & Chemical Composition
Hydrogels are polymer networks composed of 80% to 90% water or glycerin suspended in a hydrophilic starch or synthetic polymer matrix (e.g., carboxymethylcellulose, polyvinyl alcohol). Available in two primary forms:
Amorphous Hydrogel: Free-flowing gel supplied in tubes, foil packets, or spray bottles.
Fixed Sheet Hydrogel: Three-dimensional polymer sheet backed by a thin film, capable of swelling without dissolving.
Primary Mechanism of Action: Active Moisture Donation
Unlike dressings designed to trap exudate, hydrogels act as active moisture donors . When applied to dry necrotic eschar or avascular slough, water molecules migrate out of the hydrogel into the dry matrix of the eschar. This rehydrates dead tissue, re-activates dormant endogenous enzymes (collagenases, elastase), and facilitates autolytic debridement.
- Property / Aspect Amorphous Hydrogel Sheet Hydrogel
- Physical State Viscous free-flowing gel Gel sheet wafer
- Primary Mechanism Donates moisture to dry eschar/tunnels Donates moisture + minor fluid absorption
- Secondary Cover Mandatory (gauze, film, hydrocolloid) Optional (often self-adherent or film-backed)
- Wear Time / Changes Daily to every 24–48 hours 1 to 3 days
- Special Indications Packing deep dry cavities, radiation burns Painful partial-thickness burns, painful ulcers
Clinical Application Rules:
Protect Periwound Skin: Apply hydrogel strictly within the boundaries of the necrotic wound bed. Maceration occurs rapidly if amorphous hydrogel spreads onto healthy intact periwound skin.
Soothing Analgesic Effect: High water content provides localized cooling and pain reduction, making hydrogels highly effective for painful superficial burns and painful vasculitic ulcers.
Comparative Performance Matrix: Barrier & Hydrating Dressings
- Clinical Metric Hydrocolloid Wafer Transparent Film Amorphous / Sheet Hydrogel
- Primary Function Moisture retention & occlusion Semi-permeable barrier Active moisture donation
- Fluid Absorbency Low to Moderate (Gel melt) Zero (0 mL) Minimal (Sheet) / None (Amorphous)
- Moisture Mechanism Traps exudate into CMC gel Retains native vapor via MVTR Donates 80–90% water content
- Autolytic Effect High (Hypoxic enzyme trap) Moderate (Moisture retention) Maximum (Rehydrates eschar)
- Infection Status CONTRAINDICATED CONTRAINDICATED Caution (Amorphous ok with cover)
- Typical Wear Time 3 to 7 days 3 to 7 days Daily to 48h (Amorphous); 1-3d (Sheet)
- Removal Impact Residue melt (needs saline) Stretch parallel to skin Easy saline rinse